The DOI matches its Crossref record; 47 of the 50 references it cites were found in a registry or an index.
The NALP3 inflammasome is involved in the innate immune response to amyloid-β
Open accessAbstract
The fibrillar peptide amyloid-beta (A beta) has a chief function in the pathogenesis of Alzheimer's disease. Interleukin 1 beta (IL-1 beta) is a key cytokine in the inflammatory response to A beta. Insoluble materials such as crystals activate the inflammasome formed by the cytoplasmic receptor NALP3, which results in the release of IL-1 beta. Here we identify the NALP3 inflammasome as a sensor of A beta in a process involving the phagocytosis of A beta and subsequent lysosomal damage and release of cathepsin B. Furthermore, the IL-1 beta pathway was essential for the microglial synthesis of proinflammatory and neurotoxic factors, and the inflammasome, caspase-1 and IL-1 beta were critical for the recruitment of microglia to exogenous A beta in the brain. Our findings suggest that activation of the NALP3 inflammasome is important for inflammation and tissue damage in Alzheimer's disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Based on the previous literature42,43,46, we reasoned that cathepsin B leaking from the destabilized lysosomes may mediate the NLRP3 inflammasome activation upon SHIP1 inhibition11.”
From INPP5D/SHIP1 regulates endo-lysosomal function and cargo-selective phagocytosis in human microglia (2025) · cites this paper as [43]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Fibrillar Aβ (fAβ), following phagocytosis by microglia, activates the NLRP3 inflammasome and leads to increases in secretion of IL-1β and IL-18.”
From Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer’s disease (2023) · cites this paper as [78]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Sustained elevations of IL-1β have been postulated to play a key role in AD pathogenesis [6, 12–14].”
From 25-Hydroxycholesterol amplifies microglial IL-1β production in an apoE isoform-dependent manner (2020) · cites this paper as [13]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Halle et al. found that fibrillar Aβ can induce the secretion of IL-1β which depends on the presence of NLRP3.352,353”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [352]
The cited source says what the claim attributes to it.
In the citing paper
“lysosomal cathepsins, such as cathepsin B, can induce NLRP3 inflammasome activation upon leaking into the cytosol following lysosomal membrane permeabilization (LMP)42,43”
From INPP5D/SHIP1 regulates endo-lysosomal function and cargo-selective phagocytosis in human microglia (2025) · cites this paper as [43]
The cited source says what the claim attributes to it.
In the citing paper
“fAβ phagocytosis results in lysosomal dysfunction and release of lysosomal contents into the cytoplasm, including the lysosomal protease cathepsin B, which is a mediator of inflammasome activation induced by Aβ [78].”
From Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer’s disease (2023) · cites this paper as [78]
The cited source says what the claim attributes to it.
In the citing paper
“In line with these findings, another study showed that aggregated tau seeds activated the NLRP3 inflammasome in primary mouse microglia by inducing lysosomal destabilization and release of the lysosomal protease cathepsin B, similar to fAβ [78, 82].”
From Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer’s disease (2023) · cites this paper as [78]
The cited source says what the claim attributes to it.
In the citing paper
“In parallel, reduction of SHIP1 activity is poised to disinhibit signaling pathways that are involved in the phagocytosis of Aβ, which is a required step for Aβ-induced activation of the NLRP3 inflammasome [78].”
From Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer’s disease (2023) · cites this paper as [78]
In the citing paper
“Notably, Aβ also can activate NF-κB signaling and the NLRP3-ASC inflammasome [426, 427], suggesting that Aβ and tau share common mechanisms in microglia activation.”
From Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease (2020) · cites this paper as [426]
In the citing paper
“Following phagocytosis by microglia, Aβ activates the NLRP3 inflammasome leading to caspase-1 activation and IL-1β maturation and release (Halle et al., 2008).”
From Alzheimer Disease: An Update on Pathobiology and Treatment Strategies (2019) · cites this paper as Halle et al., 2008
In the citing paper
“Fibrillar Aβ amyloids can induce the secretion of IL-1β from microglia, via the NLRP3 inflammasome (228, 249).”
From The gut-brain axis: how microbiota and host inflammasome influence brain physiology and pathology (2020) · cites this paper as [228]
In the citing paper
“Importantly, researchers also found that ASC-, caspase-1-, IL-1 receptor-, and MyD88-deficient mice had less recruitment of microglia and mononuclear phagocytes to Aβ in the brain as compared to the wild type control after the injection of Aβ into the striatum (228).”
From The gut-brain axis: how microbiota and host inflammasome influence brain physiology and pathology (2020) · cites this paper as [228]
In the citing paper
“NLRP3 has been shown to respond to sterile stimuli, including asbestos, silica, MSU and CPPD crystals55, cholesterol crystals and β-amyloid fibrils56.”
From Sterile inflammation: sensing and reacting to damage (2010) · cites this paper as [56]
In the citing paper
“Furthermore, there is only partial inhibition of the neutrophil infiltration and IL-1β production associated with sterile inflammation in response to cholesterol crystals44,56,59,67.”
From Sterile inflammation: sensing and reacting to damage (2010) · cites this paper as [56]
In the citing paper
“However, cathepsin b-deficient macrophages have no impairment in IL-1β production in response to certain NLRP3 agonists, including LPS plus ATP, or MSU crystals, despite the impairment in their response to silica44,56,59,67.”
From Sterile inflammation: sensing and reacting to damage (2010) · cites this paper as [56]
In the citing paper
“evidence to support this are the observations that artificial lysosomal rupture alone can activate NLRP3 and that pharmacological inhibition or genetic depletion of cathepsin b results in inhibition of caspase 1 activation, although this inhibition was only partial44,56,59.”
From Sterile inflammation: sensing and reacting to damage (2010) · cites this paper as [56]
In the citing paper
“In support of this, direct treatment of ATP on primed microglia is sufficient for maturation and release of IL-1β in vitro (Halle et al, 2008) and does so via the P2X 7 receptor (Colomar et al, 2003) expressed on microglia (Monif et al, 2009).”
From Repeated Social Defeat, Neuroinflammation, and Behavior: Monocytes Carry the Signal (2017) · cites this paper as Halle et al, 2008
In the citing paper
“In particular, microglial NLRP3 has been shown to be a major driver of amyloid beta and tau toxicity in AD, suggesting its activation has important implications for disease progression (Halle et al, 2008; Venegas et al, 2017; Ising et al, 2019).”
From Mechanisms of DNA damage-mediated neurotoxicity in neurodegenerative disease (2022) · cites this paper as Halle et al, 2008
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gout-associated uric acid crystals activate the NALP3 inflammasome
Martinon, F., Pétrilli, V., Mayor, A., Tardivel, A., & Tschopp, J. (2006) · Nature · doi:10.1038/nature04516 · Cited by 5,326
Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160
Cryopyrin activates the inflammasome in response to toxins and ATP
Mariathasan, S., Weiss, D. S., Newton, K., McBride, J., O'Rourke, K., Roose-Girma, M., Lee, W. P., Weinrauch, Y., Monack, D. M., & Dixit, V. M. (2006) · Nature · doi:10.1038/nature04515 · Cited by 3,080
Innate Immune Activation Through Nalp3 Inflammasome Sensing of Asbestos and Silica
Dostert, C., Pétrilli, V., Van Bruggen, R., Steele, C., Mossman, B. T., & Tschopp, J. (2008) · Science · doi:10.1126/science.1156995 · Cited by 2,658
Germline Transmission and Tissue-Specific Expression of Transgenes Delivered by Lentiviral Vectors
Lois, C., Hong, E. J., Pease, S., Brown, E. J., & Baltimore, D. (2002) · Science · doi:10.1126/science.1067081 · Cited by 1,992
Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease.
Griffin, W. S., Stanley, L. C., Ling, C., White, L., MacLeod, V, Perrot, L. J., White, C. L., & Araoz, C. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.19.7611 · Cited by 1,777
Agostini, L., Martinon, F., Burns, K., McDermott, M. F., Hawkins, P. N., & Tschopp, J. (2004) · Immunity · doi:10.1016/s1074-7613(04)00046-9 · Cited by 1,768
Altered Cytokine Export and Apoptosis in Mice Deficient in Interleukin-1β Converting Enzyme
Kuida, K., Lippke, J. A., Ku, G., Harding, M. W., Livingston, D. J., Su, M. S. S., & Flavell, R. A. (1995) · Science · doi:10.1126/science.7535475 · Cited by 1,631
A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity
Weggen, S., Eriksen, J. L., Das, P., Sagi, S. A., Wang, R., Pietrzik, C. U., Findlay, K. A., Smith, T. E., Murphy, M. P., Bulter, T., et al. (2001) · Nature · doi:10.1038/35102591 · Cited by 1,388
Simard, A. R., Soulet, D., Gowing, G., Julien, J.-P., & Rivest, S. (2006) · Neuron · doi:10.1016/j.neuron.2006.01.022 · Cited by 1,265
Flagged first, then by citations
3 of the 50 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 301–400 of 1,015
The Role of NLRP3 Inflammasome in Alzheimer’s Disease and Potential Therapeutic Targets
Liang, T., Zhang, Y., Wu, S., Chen, Q., & Wang, L. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.845185 · Cited by 226
The NLRP3 inflammasome: A sensor of immune danger signals
Cassel, S. L., Joly, S., & Sutterwala, F. S. (2009) · Seminars in Immunology · doi:10.1016/j.smim.2009.05.002 · Cited by 226
Chang, Y.-P., Ka, S., Hsu, W., Chen, A., Chao, L. K., Lin, C.-C., Hsieh, C.-C., Chen, M., Chiu, H.-W., Ho, C., et al. (2014) · Journal of Cellular Physiology · doi:10.1002/jcp.24903 · Cited by 220
Bulau, A., Nold, M. F., Li, S., Nold‐Petry, C. A., Fink, M., Mansell, A. S., Schwerd, T., Hong, J., Rubartelli, A., Dinarello, C. A., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1324140111 · Cited by 217
IL ‐1β and IL ‐18: inflammatory markers or mediators of hypertension?
Krishnan, S. M., Sobey, C. G., Latz, E., Mansell, A. S., & Drummond, G. R. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12876 · Cited by 219
Self-citationLippai, D., Bala, S., Petrasek, J., Csák, T., Levin, I., Kurt‐Jones, E. A., & Szabó, G. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.1212659 · Cited by 220
Mechanism of action of licensed vaccine adjuvants
Tritto, E., Mosca, F., & Gregorio, E. D. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.01.084 · Cited by 211
Cell death in the pathogenesis of systemic lupus erythematosus and lupus nephritis
Mistry, P., & Kaplan, M. J. (2016) · Clinical Immunology · doi:10.1016/j.clim.2016.08.010 · Cited by 215
Pellegrini, C., Antonioli, L., López‐Castejón, G., Blandizzi, C., & Fornai, M. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00036 · Cited by 220
Mechanistic insights from inflammasome structures
Fu, J., Schroder, K., & Wu, H. (2024) · Nature reviews. Immunology · doi:10.1038/s41577-024-00995-w · Cited by 223
The NLR family of innate immune and cell death sensors
Sundaram, B., Tweedell, R. E., Kumar, S. P., & Kanneganti, T. (2024) · Immunity · doi:10.1016/j.immuni.2024.03.012 · Cited by 224
Hoegen, T., Tremel, N., Klein, M., Angele, B., Wagner, H., Kirschning, C., Pfister, H.-W., Fontana, A., Hammerschmidt, S., & Koedel, U. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100790 · Cited by 211
Inflammation in the early stages of neurodegenerative pathology
Khandelwal, P. J., Herman, A. M., & Moussa, C. (2011) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2011.07.002 · Cited by 218
Kuwar, R., Rolfe, A., Di, L., Xu, H., Liu, H., Jiang, Y., Zhang, S., & Sun, D. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1471-y · Cited by 208
Serrano‐Puebla, A., & Boya, P. (2016) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12966 · Cited by 204
Canonical and non-canonical effects of the NLRP3 inflammasome in kidney inflammation and fibrosis
Lorenz, G., Darisipudi, M. N., & Anders, H. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft332 · Cited by 207
Identification of QS-21 as an Inflammasome-activating Molecular Component of Saponin Adjuvants
Marty-Roix, R., Vladimer, G. I., Pouliot, K., Weng, D., Buglione‐Corbett, R., West, K., MacMicking, J. D., Chee, J., Wang, S., Lu, S., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.683011 · Cited by 217
Kuroda, E., Ishii, K. J., Uematsu, S., Ohata, K., Coban, C., Akira, S., Aritake, K., Urade, Y., & Morimoto, Y. (2011) · Immunity · doi:10.1016/j.immuni.2011.03.019 · Cited by 213
Old Maids: Aging and Its Impact on Microglia Function
Koellhoffer, E. C., McCullough, L. D., & Ritzel, R. M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18040769 · Cited by 213
Saha, S., Buttari, B., Profumo, E., Tucci, P., & Saso, L. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.787258 · Cited by 185
New Insights into Mechanisms Controlling the NLRP3 Inflammasome and Its Role in Lung Disease
Nardo, D. D., Nardo, C. M. D., & Latz, E. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.09.007 · Cited by 206
Self-citationSokolovska, A., Becker, C., Ip, W., Rathinam, V. A. K., Brudner, M., Paquette, N., Tanne, A. J., Vanaja, S. K., Moore, K. J., Fitzgerald, K. A., et al. (2013) · Nature Immunology · doi:10.1038/ni.2595 · Cited by 205
Self-citationNLRP3 Inflammasome Activation Induced by Engineered Nanomaterials
Sun, B., Wang, X., Ji, Z., Li, R., & Xia, T. (2012) · Small · doi:10.1002/smll.201201962 · Cited by 213
Mitochondria and the NLRP3 inflammasome: physiological and pathological relevance
Yu, J., & Lee, M. (2016) · Archives of Pharmacal Research · doi:10.1007/s12272-016-0827-4 · Cited by 209
Toll-like receptor (TLR) and inflammasome actions in the central nervous system
Hanamsagar, R., Hanke, M. L., & Kielian, T. (2012) · Trends in Immunology · doi:10.1016/j.it.2012.03.001 · Cited by 203
Bordt, E. A., & Polster, B. M. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.07.033 · Cited by 202
Hypothalamic Inflammation in the Control of Metabolic Function
Valdearcos, M., Xu, A. W., & Koliwad, S. K. (2015) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021014-071656 · Cited by 209
NOD-like receptors and the innate immune system: Coping with danger, damage and death
Kersse, K., Bertrand, M. J. M., Lamkanfi, M., & Vandenabeele, P. (2011) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2011.09.003 · Cited by 214
Involvement of inflammasome activation in lipopolysaccharide-induced mice depressive-like behaviors
Zhang, Y., Liu, L., Peng, Y., Liu, Y., Wu, T., Shen, X., Zhou, J., Sun, D., Huang, A., Wang, X., et al. (2014) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12170 · Cited by 200
NLRP3 Inflammasome as a Novel Player in Myocardial Infarction
Takahashi, M. (2014) · International Heart Journal · doi:10.1536/ihj.13-388 · Cited by 200
Innate Immunity and Neuroinflammation
Shastri, A., Bonifati, D. M., & Kishore, U. (2013) · Mediators of Inflammation · doi:10.1155/2013/342931 · Cited by 207
Encephalomyocarditis Virus Viroporin 2B Activates NLRP3 Inflammasome
Ito, M., Yanagi, Y., & Ichinohe, T. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002857 · Cited by 199
α-Synuclein Alters Toll-Like Receptor Expression
Béraud, D., Twomey, M. A., Bloom, B., Mittereder, A., Ton, V., Neitzke, K., Chasovskikh, S., Mhyre, T. R., & Maguire‐Zeiss, K. A. (2011) · Frontiers in Neuroscience · doi:10.3389/fnins.2011.00080 · Cited by 203
Kalantari, P., DeOliveira, R. B., Chan, J., Corbett, Y., Rathinam, V. A. K., Stutz, A., Latz, E., Gazzinelli, R. T., Golenbock, D. T., & Fitzgerald, K. A. (2014) · Cell Reports · doi:10.1016/j.celrep.2013.12.014 · Cited by 198
Self-citationMultiple roles of caspase-8 in cell death, inflammation, and innate immunity
Ørning, P., & Lien, E. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.3mr0420-305r · Cited by 206
Savage, C. D., Lopez-Castejon, G., Denes, A., & Brough, D. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00288 · Cited by 197
The role of lysosomal cysteine cathepsins in NLRP3 inflammasome activation
Campden, R. I., & Zhang, Y. (2019) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2019.02.015 · Cited by 203
Kinnunen, K., Petrovski, G., Moe, M. C., Berta, A., & Kaarniranta, K. (2011) · Acta Ophthalmologica · doi:10.1111/j.1755-3768.2011.02179.x · Cited by 202
The role of inflammasome in Alzheimer's disease
Liu, L., & Chan, C. (2014) · Ageing Research Reviews · doi:10.1016/j.arr.2013.12.007 · Cited by 196
Vajjhala, P. R., Mirams, R. E., & Hill, J. M. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.381228 · Cited by 205
ATP-P2X4 signaling mediates NLRP3 inflammasome activation: A novel pathway of diabetic nephropathy
Chen, K., Zhang, J., Zhang, W., Zhang, J., Yang, J., Li, K., & He, Y. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.02.009 · Cited by 198
Neurodegenerative Disease and the NLRP3 Inflammasome
Holbrook, J. A., Jarosz-Griffiths, H., Caseley, E. A., Reyna, S. J. L., Poulter, J. A., Williams‐Gray, C. H., Peckham, D. G., & McDermott, M. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.643254 · Cited by 201
Soluble Aβ oligomers and protofibrils induce NLRP3 inflammasome activation in microglia
Lučiūnaitė, A., McManus, R. M., Jankunec, M., Rácz, I., Dansokho, C., Dalgėdienė, I., Schwartz, S., Brosseron, F., & Heneka, M. T. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.14945 · Cited by 192
Inoue, M., Williams, K. L., Oliver, T. N., Vandenabeele, P., Rajan, J. V., Miao, E. A., & Shinohara, M. L. (2012) · Science Signaling · doi:10.1126/scisignal.2002767 · Cited by 193
Of inflammasomes and pathogens – sensing of microbes by the inflammasome
Bauernfeind, F. G., & Hornung, V. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201201771 · Cited by 198
Self-citationRoles of the NLRP3 inflammasome in the pathogenesis of diabetic nephropathy
Qiu, Y.-Y., & Tang, L. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.11.004 · Cited by 198
An NLRP3-specific inflammasome inhibitor attenuates crystal-induced kidney fibrosis in mice
Ludwig‐Portugall, I., Bartok, E., Dhana, E., Evers, B. D. G., Primiano, M. J., Hall, J. P., Franklin, B. S., Knolle, P. A., Hornung, V., Hartmann, G., et al. (2016) · Kidney International · doi:10.1016/j.kint.2016.03.035 · Cited by 195
Self-citationWu, A., Zhou, X., Qiao, G., Yu, L., Tang, Y., Yan, L., Qiu, W., Pan, R., Yu, C., Law, B. Y. K., et al. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101202 · Cited by 196
Krishnan, S. M., Dowling, J. K., Ling, Y. H., Diep, H., Chan, C. T., Ferens, D. M., Kett, M. M., Pinar, A. A., Samuel, C. S., Vinh, A., et al. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13230 · Cited by 193
Self-citationMitophagy: a balance regulator of NLRP3 inflammasome activation
Kim, M., Yoon, J., & Ryu, J.-H. (2016) · BMB Reports · doi:10.5483/bmbrep.2016.49.10.115 · Cited by 202
β-Amyloid Clustering around ASC Fibrils Boosts Its Toxicity in Microglia
Friker, L. L., Scheiblich, H., Hochheiser, I. V., Brinkschulte, R., Riedel, D., Latz, E., Geyer, M., & Heneka, M. T. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.02.025 · Cited by 191
Self-citationTREM2 dependent and independent functions of microglia in Alzheimer’s disease
Hou, J., Chen, Y., Grajales-Reyes, G., & Colonna, M. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00588-y · Cited by 191
Mulay, S. R., Evan, A. P., & Anders, H. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft248 · Cited by 190
Westwell-Roper, C. Y., Dai, D. L., Soukhatcheva, G., Potter, K. J., van Rooijen, N., Ehses, J. A., & Verchere, C. B. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002854 · Cited by 193
Di Benedetto, G., Burgaletto, C., Bellanca, C. M., Munafò, A., Bernardini, R., & Cantarella, G. (2022) · Cells · doi:10.3390/cells11172728 · Cited by 189
β-amyloid, microglia, and the inflammasome in Alzheimer’s disease
Gold, M., & El Khoury, J. (2015) · Seminars in Immunopathology · doi:10.1007/s00281-015-0518-0 · Cited by 187
AIM2 inflammasome contributes to brain injury and chronic post-stroke cognitive impairment in mice
Kim, H., Seo, J., Lee, S., Ha, K., Choi, B. T., Shin, Y., Yun, Y.-J., & Shin, H. K. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.03.011 · Cited by 199
Inflammasome signaling at the heart of central nervous system pathology
Chakraborty, S., Kaushik, D. K., Gupta, M., & Basu, A. (2010) · Journal of Neuroscience Research · doi:10.1002/jnr.22343 · Cited by 189
High‐mobility group box‐1 in sterile inflammation
Tsung, A., Tohme, S., & Billiar, T. R. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12276 · Cited by 187
Meixenberger, K., Pache, F. C., Eitel, J., Schmeck, B., Hippenstiel, S., Slevogt, H., N’Guessan, P. D., Witzenrath, M., Netea, M. G., Chakraborty, T., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901346 · Cited by 186
How neurons die in Alzheimer's disease: Implications for neuroinflammation
Mangalmurti, A., & Lukens, J. R. (2022) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2022.102575 · Cited by 195
The mechanism of NLRP3 inflammasome activation and its pharmacological inhibitors
Zhan, X., Li, Q., Xu, G., Xiao, X., & Bai, Z. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1109938 · Cited by 203
Tomalka, J. A., Ganesan, S., Azodi, E., Patel, K., Majmudar, P. R., Hall, B. A., Fitzgerald, K. A., & Hise, A. G. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002379 · Cited by 188
Self-citationAmyloid fibrils are the molecular trigger of inflammation in Parkinson's disease
Gustot, A., Gallea, J. I., Sarroukh, R., Celej, M. S., Ruysschaert, J., & Raussens, V. (2015) · Biochemical Journal · doi:10.1042/bj20150617 · Cited by 190
Interleukin-1β (IL-1β) Processing Pathway
Weber, A., Wasiliew, P., & Kracht, M. (2010) · Science Signaling · doi:10.1126/scisignal.3105cm2 · Cited by 184
Exploiting microglial and peripheral immune cell crosstalk to treat Alzheimer’s disease
Dionisio-Santos, D. A., Olschowka, J. A., & O’Banion, M. K. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1453-0 · Cited by 184
The involvement of NLRP3 inflammasome in the treatment of Alzheimer’s disease
Feng, Y.-S., Tan, Z., Wu, L., Dong, F., & Zhang, F. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101192 · Cited by 186
Migration of neutrophils targeting amyloid plaques in Alzheimer's disease mouse model
Baik, S. H., Cha, M.-Y., Hyun, Y.-M., Cho, H., Hamza, B., Kim, D. K., Han, S.-H., Choi, H., Kim, K. H., Moon, M., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.01.003 · Cited by 181
“However, controversial findings regarding the toxic properties of infiltrated immune cells in the central nervous system diseases have been reported (Halle et al., 2008; Heneka et al., 2013).”
BackgroundNew role of P2X7 receptor in an Alzheimer’s disease mouse model
Martin, E., Amar, M., Dalle, C., Youssef, I., Boucher, C., Le Duigou, C., Brückner, M., Prigent, A., Sazdovitch, V., Halle, A., et al. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0108-3 · Cited by 187
Self-citationBeta-amyloid activates NLRP3 inflammasome via TLR4 in mouse microglia
Liu, Y., Dai, Y., Li, Q., Chen, C., Chen, H., Song, Y., Hua, F., & Zhang, Z. (2020) · Neuroscience Letters · doi:10.1016/j.neulet.2020.135279 · Cited by 183
Microglial Phenotype and Adaptation
Eggen, B. J. L., Raj, D. D. A., Hanisch, U., & Boddeke, H. W. G. M. (2013) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-013-9490-4 · Cited by 187
Case, C. L., Shin, S., & Roy, C. R. (2009) · Infection and Immunity · doi:10.1128/iai.01382-08 · Cited by 181
Hu, Q., Zhang, T., Yi, L., Zhou, X., & Mi, M. (2017) · BioFactors · doi:10.1002/biof.1395 · Cited by 180
Impaired insulin signalling and allostatic load in Alzheimer disease
Felice, F. G. D., Gonçalves, R. A., & Ferreira, S. T. (2022) · Nature reviews. Neuroscience · doi:10.1038/s41583-022-00558-9 · Cited by 183
Hou, B., Zhang, Y., Liang, P., He, Y., Peng, B., Liu, W., Han, S., Yin, J., & He, X. (2020) · Cell Death & Disease · doi:10.1038/s41419-020-2565-2 · Cited by 187
Recent Advances of the NLRP3 Inflammasome in Central Nervous System Disorders
Zhou, K., Shi, L., Wang, Y., Chen, S., & Zhang, J. (2016) · Journal of Immunology Research · doi:10.1155/2016/9238290 · Cited by 175
Free fatty acids as modulators of the NLRP3 inflammasome in obesity/type 2 diabetes
Legrand-Poels, S., Esser, N., L’homme, L., Scheen, A., Paquot, N., & Piette, J. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.08.013 · Cited by 194
Programmed Necrosis and Disease:We interrupt your regular programming to bring you necroinflammation
Kim, E. H., Wong, S., & Martinez, J. (2018) · Cell Death and Differentiation · doi:10.1038/s41418-018-0179-3 · Cited by 181
Corcoran, S. E., Halai, R., & Cooper, M. A. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000171 · Cited by 180
Santoni, G., Cardinali, C., Morelli, M. B., Santoni, M., Nabissi, M., & Amantini, C. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0239-2 · Cited by 182
Lighting the fires within: the cell biology of autoinflammatory diseases
Park, H., Bourla, A. B., Kastner, D. L., Colbert, R. A., & Siegel, R. M. (2012) · Nature reviews. Immunology · doi:10.1038/nri3261 · Cited by 178
Elimination of the NLRP3-ASC Inflammasome Protects against Chronic Obesity-Induced Pancreatic Damage
Youm, Y., Adijiang, A., Vandanmagsar, B., Burk, D. H., Ravussin, A., & Dixit, V. D. (2011) · Endocrinology · doi:10.1210/en.2011-1326 · Cited by 187
HOOK, V. Y. H., Yoon, M. C., Mosier, C., Ito, G., Podvin, S., Head, B. P., Rissman, R. A., O’Donoghue, A. J., & Hook, G. (2020) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2020.140428 · Cited by 177
Béraud, D., Hathaway, H. A., Trecki, J., Chasovskikh, S., Johnson, D. A., Johnson, J. A., Federoff, H. J., Shimoji, M., Mhyre, T. R., & Maguire‐Zeiss, K. A. (2012) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-012-9401-0 · Cited by 179
Mite allergen is a danger signal for the skin via activation of inflammasome in keratinocytes
Dai, X., Sayama, K., Tohyama, M., Shirakata, Y., Hanakawa, Y., Tokumaru, S., Yang, L., Hirakawa, S., & Hashimoto, K. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.12.006 · Cited by 175
Ismael, S., Nasoohi, S., & Ishrat, T. (2018) · Journal of Neurotrauma · doi:10.1089/neu.2017.5344 · Cited by 173
Manganese promotes the aggregation and prion-like cell-to-cell exosomal transmission of α-synuclein
Harischandra, D. S., Rokad, D., Neal, M. P., Ghaisas, S., Manne, S., Sarkar, S., Panicker, N., Zenitsky, G. D., Jin, H., Lewis, M. M., et al. (2019) · Science Signaling · doi:10.1126/scisignal.aau4543 · Cited by 171
IL-1 family cytokines trigger sterile inflammatory disease
Lukens, J. R., Gross, J. M., & Kanneganti, T. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00315 · Cited by 178
Carcinogenesis mechanisms of Fusobacterium nucleatum
Gholizadeh, P., Eslami, H., & Kafil, H. S. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.02.102 · Cited by 175
Hung, S.-C., Choi, C. H., Sadier, N. S., Johnson, L., Atanasova, K. R., Sellami, H., Yilmaz, Ö., & Ojcius, D. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070210 · Cited by 176
The intersection of cell death and inflammasome activation
Vince, J. E., & Silke, J. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2205-2 · Cited by 180
Jang, J., Park, S., Jin Hur, H., Cho, H.-J., Hwang, I., Pyo Kang, Y., Im, I., Lee, H., Lee, E., Yang, W., et al. (2016) · Nature Communications · doi:10.1038/ncomms13129 · Cited by 166
Ortiz‐Virumbrales, M., Moreno, C. L., Kruglikov, I., Marazuela, P., Sproul, A. A., Jacob, S., Zimmer, M., Paull, D. J., Zhang, B., Schadt, E. E., et al. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0475-z · Cited by 179
Sarkar, S., Rokad, D., Malovic, E., Luo, J., Harischandra, D. S., Jin, H., Anantharam, V., Huang, X., Lewis, M., Kanthasamy, A., et al. (2019) · Science Signaling · doi:10.1126/scisignal.aat9900 · Cited by 171
Zeller, M. V., Dias, D., Sebastião, A. M., & Valente, C. A. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210268 · Cited by 179
Inflammasomes link vascular disease with neuroinflammation and brain disorders
Lénárt, N., Brough, D., & Dénes, Á. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x16662043 · Cited by 170
Structure, Activation and Regulation of NLRP3 and AIM2 Inflammasomes
Sharma, M., & de Alba, E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020872 · Cited by 173
Innate immune activation in neurodegenerative diseases
Castro‐Gomez, S., & Heneka, M. T. (2024) · Immunity · doi:10.1016/j.immuni.2024.03.010 · Cited by 176
The Nrf2-HO-1 system and inflammaging
O’Rourke, S. A., Shanley, L. C., & Dunne, A. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1457010 · Cited by 177
Triantafilou, K., Kar, S., Vakakis, E., Kotecha, S., & Triantafilou, M. (2012) · Thorax · doi:10.1136/thoraxjnl-2012-202182 · Cited by 161
Metadata
- Authors
- Halle, A., Hornung, V., Petzold, G. C., Stewart, C. R., Monks, B. G., Reinheckel, T., Fitzgerald, K. A., Latz, E., Moore, K. J., & Golenbock, D. T.
- Affiliations
- University of Massachusetts Chan Medical School (US)
- Harvard University (US)
- University of Freiburg (DE)
- Corresponding author
- Golenbock, Douglas T
- ORCID
- Venue
- Nature Immunology
- Published
- 2008-07-11
- Volume
- 9
- Issue
- 8
- Pages
- 857-865
- ISSN
- 1529-2908 (ISSN-L)
- 1529-2916
- PMC
- PMC3101478
- OpenAlex
- W2119098586
- Cited by
- 2,441
- References
- 50
- Citations by year
- 2026: 92 · 2025: 124 · 2024: 143 · 2023: 165 · 2022: 191 · 2021: 188 · 2020: 169 · 2019: 151 · 2018: 136 · 2017: 139 · 2016: 138 · 2015: 146 · 2014: 149 · 2013: 153 · 2012: 98
- FWCI
- 35.20
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Immunology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- eScholarship@UMassChan (submittedVersion)
- MPG.PuRe (Max Planck Society) (submittedVersion)
- Funders
- National Institute on Aging (R01AG020255, AG20255)
- National Institute of General Medical Sciences (R37GM054060, R01GM054060, GM 54060)
- National Institute of Allergy and Infectious Diseases (AI065483, R01AI065483)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- NLRP3 inflammasome, amyloid-beta, Alzheimer's disease, innate immunity, IL-1β, caspase-1, microglia, phagocytosis, lysosomal damage, cathepsin B, neuroinflammation, neurotoxicity
- MeSH terms
- NLR Family, Pyrin Domain-Containing 3 Protein, Alzheimer Disease, Carrier Proteins, Immunity, Innate, Inflammation, Amyloid beta-Peptides, Inflammation Mediators
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
